AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Zelira Therapeutics Ltd

0.490

-0.010-2.00%

Volume:15.92K

Turnover:7.80K

Market Cap:5.83M

PE:-1.55

High:0.500

Open:0.500

Low:0.485

Close:0.500

52wk High:1.150

52wk Low:0.310

Shares:11.90M

Float Shares:6.44M

Volume Ratio:11.13

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.316

EPS(LYR):-0.316

ROE:-266.82%

ROA:-83.30%

PB:-1.31

PE(LYR):-1.55

Loading ...

Overview Company News Filings

BRIEF-Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV

BUZZ-Australia's Zelira Therapeutics surges on $33 million funding for drug trial

Zelira Therapeutics Ltd - US$33M Fundraising Into Zeliras Hope 1 Spv

THOMSON REUTERS

ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore

The West Australian

Zelira Therapeutics Ltd-Proposed Issue of Securities - Zld

THOMSON REUTERS

Zelira Therapeutics Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZLD.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ZLD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ZLD.AU\",,,,,undefined,":{"symbol":"ZLD.AU","market":"AU","secType":"STK","nameCN":"Zelira Therapeutics Ltd","latestPrice":0.49,"timestamp":1772156996321,"preClose":0.5,"halted":0,"volume":15922,"delay":0,"changeRate":-0.020000000000000018,"nameEN":"Zelira Therapeutics Ltd","floatShares":6436754,"shares":11897155,"eps":-0.31593,"marketStatus":"Trading","change":-0.01,"latestTime":"02-27 14:03:46 AEDT","open":0.5,"high":0.5,"low":0.485,"amount":7801,"amplitude":0.03,"askPrice":0.49,"askSize":171,"bidPrice":0.485,"bidSize":14783,"shortable":3,"etf":0,"ttmEps":-0.31593,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772168400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.5,"openAndCloseTimeList":[[1772146800000,1772168400000]],"volumeRatio":11.134455,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ZLD.AU\",,,,,undefined,":{"symbol":"ZLD.AU","floatShares":6436754,"roa":"-83.30%","roe":"-266.82%","lyrEps":-0.31593,"volumeRatio":11.134455,"shares":11897155,"dividePrice":0,"high":0.5,"amplitude":0.03,"preClose":0.5,"low":0.485,"week52Low":0.31,"pbRate":"-1.31","psRate":"8886.59","week52High":1.15,"institutionHeld":0,"latestPrice":0.49,"committee":0.97713,"eps":-0.31593,"divideRate":0,"volume":15922,"delay":0,"ttmEps":-0.31593,"open":0.5,"prevYearClose":0.425,"prevWeekClose":0.52,"prevMonthClose":0.65,"prevQuarterClose":0.425,"fiveDayClose":0.52,"twentyDayClose":0.65,"sixtyDayClose":0.345},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZLD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2022-04-14","symbol":"ZLD.AU","defaultRemindTime":1649894400000,"type":"split","dateTimestamp":1649858400000,"forFactor":175,"toFactor":1,"ratio":175}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZLD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZLD.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603952233","title":"BRIEF-Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603952233?lang=en_us&edition=fundamental","pubTime":"2026-01-16 14:22","pubTimestamp":1768544551,"startTime":"0","endTime":"0","summary":"BRIEF-Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPVJan 16 (Reuters) - Zelira Therapeutics Ltd ZLD.AX:US$33M FUNDRAISING INTO ZELIRAS HOPE 1 SPVFurther company coverage: ZLD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YG0X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","ZLD.AU","BK7096","BK7502"],"gpt_icon":0},{"id":"2603934514","title":"BUZZ-Australia's Zelira Therapeutics surges on $33 million funding for drug trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2603934514","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603934514?lang=en_us&edition=fundamental","pubTime":"2026-01-16 07:44","pubTimestamp":1768520683,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Zelira Therapeutics surges on $33 million funding for drug trial** Shares of Zelira Therapeutics ZLD.AX rise as much as 151.4% to A$0.905, hitting their highest level since Nov. 15, 2024** Stock marks its biggest intraday pct gain since May 31, 2023** Biopharma co inks deal with TGC Biotechnology fund to raise $33 million** Says funding for its HOPE1 SPV, financial structure created by co to fund development & clinical trials for its cannabinoid drug HOPE 1 ** Stock has gained 125% so far this week, up nearly 100% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nL4N3YG26B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","ZLD.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2603931608","title":"Zelira Therapeutics Ltd - US$33M Fundraising Into Zeliras Hope 1 Spv","url":"https://stock-news.laohu8.com/highlight/detail?id=2603931608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603931608?lang=en_us&edition=fundamental","pubTime":"2026-01-16 07:04","pubTimestamp":1768518265,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7502","ZLD.AU","BK7096"],"gpt_icon":0},{"id":"2603524309","title":"ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore","url":"https://stock-news.laohu8.com/highlight/detail?id=2603524309","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603524309?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:03","pubTimestamp":1768514625,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is…biopharmaceutical minnow Zelira Therapeutics, which landed a transformational US$33 million funding deal to fast-track its HOPE 1 autism drug towards FDA approval.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-21327292/51ec86d5d002287b0d7df09af68cdfe012d030cc.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21327292/51ec86d5d002287b0d7df09af68cdfe012d030cc.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-zelira-linq-dalaroo-and-osteopore-c-21327292","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-zelira-linq-dalaroo-and-osteopore-c-21327292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK7126","BK7508","BK7096","LNQ.AU","BK7095","ZLD.AU","BK7502","DAL.AU","OSX.AU","UGL"],"gpt_icon":1},{"id":"2584994533","title":"Zelira Therapeutics Ltd-Proposed Issue of Securities - Zld","url":"https://stock-news.laohu8.com/highlight/detail?id=2584994533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584994533?lang=en_us&edition=fundamental","pubTime":"2025-11-19 12:27","pubTimestamp":1763526472,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUECFBYNZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","ZLD.AU","BK7096","BK7502"],"gpt_icon":0},{"id":"2578698621","title":"Zelira Therapeutics Ltd-Quarterly Activities/Appendix 4C Cash Flow Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2578698621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578698621?lang=en_us&edition=fundamental","pubTime":"2025-10-27 11:33","pubTimestamp":1761535989,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUE6GCNTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7502","BK7096","ZLD.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}